Suppliers / Jubilant Pharmaceuticals

Jubilant Pharmaceuticals

United States Updated 9 July 2026

Jubilant Pharmaceuticals is an API manufacturer based in United States. It appears in 264 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, MPA (SE) and INFARMED (PT).

0
active US DMFs
0
valid CEPs
0
registered plants
264
filings across 6 regulators

What they file, and where

Molecule Regulators Docs
Dalfampridine SFDA (Saudi Arabia) 1
Levocetirizine Dihydrochloride SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 109 None
MPA (SE) 91 None
INFARMED (PT) 27 None
DKMA (DK) 20 None
AEMPS (ES) 16 None
BRELA (TZ) 1 None

Questions about Jubilant Pharmaceuticals

Does Jubilant Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Jubilant Pharmaceuticals. It does have 264 filings with 6 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
What does Jubilant Pharmaceuticals make?
2 molecules are on record against Jubilant Pharmaceuticals, including Dalfampridine and Levocetirizine Dihydrochloride. Each links through to that molecule's full manufacturer list.
Where does Jubilant Pharmaceuticals file?
Filings are on record with EMA, MPA (SE), INFARMED (PT), DKMA (DK) and 2 other regulators, 264 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jubilant Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability